Measuring nerve activity in intestinal biopsies from IBS patients and healthy individuals
Official title: Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)
Run by KU Leuven · NCT01912313 · Data updated 2026-11-12
This study is testing a new way to look at nerve activity in the intestines of people with Irritable Bowel Syndrome (IBS) and healthy individuals to better understand how their nervous systems work.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 99999999 (estimated) |
| Sponsor | KU Leuven Academic / other |
| Locations | 1 site (Leuven, Vlaams-Brabant) |
| Status | Recruiting |
| Started | August 2013 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | March 20, 2026 |
| Trial ID | NCT01912313 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with IBS according to ROME III criteria and healthy subjects.
✕Probably not a fit
Patients with complaints unrelated to IBS will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study involves taking rectal biopsies from individuals diagnosed with Irritable Bowel Syndrome (IBS) and healthy subjects. The biopsies will be used to isolate the submucosal plexus for live nerve recordings, calcium imaging, immunohistochemistry, and mRNA isolation. The primary goal is to advance understanding of the enteric nervous system in IBS by developing a unique method for live imaging of nerve activity in human intestinal biopsies. This innovative approach aims to provide insights that have not been previously reported in other research.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of IBS and lead to improved diagnostic and therapeutic strategies for patients.
How similar studies have gone: This approach is novel and has not been previously reported by other research groups.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * IBS patients (based on ROME III Criteria) * Healthy subjects Exclusion Criteria: \- All subjects with not IBS related complaints
Where it's running
-
University Hospitals Leuven
Leuven, Vlaams-Brabant, Belgium Recruiting
Study contacts
- Principal investigator: Guy Boeckxstaens, MD — Catholic University Leuven and Universitary Hospitals Leuven
- Study coordinator: Koen Bellens, MSc
- Email: koen.bellens@kuleuven.be
- Phone: 0032-16-341943
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding visceral sensitivity in IBS and IBD
This study is trying to understand how the body reacts to gut sensations in people with Irritable Bowel Syndrome, active and inactive Inflammatory Bowel Disease, and healthy individuals by collecting samples and measuring different body responses.
-
Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?
This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
-
Miricell supplementation and markers of healthy aging
This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.
-
Does daily lean beef support brain health in older adults
In healthy adults aged 65 and up, this study tests whether eating lean beef every day for two weeks can influence brain health markers compared with a non-beef, protein-matched option.
-
Adaptive computerized training to boost thinking in healthy seniors and those with mild cognitive impairment
This study tests whether a computer-based training program can improve executive thinking in older adults, including those with mild cognitive impairment, and see if it also helps memory and well-being.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.